TALS - Talaris Therapeutics Inc (Healthcare: Biotechnology) Projected Earnings Date: 0000-02-29    (Delayed quote data   2025-06-30)
Last
 15.99		 Change
 ⇓ -0.55   (-3.33%)		 Volume
  137,812
Open
 16.62		 High
 16.74		 Low
 15.77
8EMA (Daily)
 16.87		 40EMA (Daily)
 17.02		 50EMA (Daily)
 16.90		 STO (Daily)
 10.787		 MACD Hist (Daily)
 -0.627
8EMA (Weekly)
 16.791		 40EMA (Weekly)
 17.59		 50EMA (Weekly)
 17.71		 STO (Weekly)
 70.348		 MACD Hist (Weekly)
 0.402
Company Profile
Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com